As both PADI4 and importin appear to be overexpressed in some cancer types, and PADI4 must be transported within the nucleus to citrullinate histones and start de-condensation, the use of drugs hampering the binding of this enzyme to importin could provide a therapeutic approach to stop cancer progression. Here, PADI4 is linked to cancer.